1 Ûstùn TB, Sartorius N. Mental Illness in General Health Care: An International Study. Chichester, UK: John Wiley & sons; 1995.
2 Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31(6):761–77.
3 Mast van der RC, Roest FHJ. Delirium after cardiac surgery:
Am critical review. J Psychosom Res. 1996;41:13–30.
4 Arolt V, Driessen M, Schürmann A. Häufigkeit und Behandlungsbedarf von Alkoholismus bei internistischen und chirurgischen Krankenhauspatienten. Fortschr Neurol Psychiatr. 1995;63:283–8.
5 Lang UE, Walter M. Depression in the Context of Medical Dis-
orders: New Pharmacological Pathways Revisited. Neurosignals. 2017;25:54–73.
6 Tuch A. Somatisch-psychische Komorbidität in Schweizer Akutspitälern. Prävalenz und Inanspruchnahme. (Obsan Bulletin 1/2018). Neuchâtel: Schweizerisches Gesundheitsobservatorium.
7 Chang CK, Hayes RD, Perera G, Broadbent MTM, Fernandes AC, Lee WE, et al. Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London. PLoS One. 2011;6:e19590.
8 Dong Y, Noorani F, Vyas R, Balgobin C, Torres-Llenza V, Crone C. Managing Anxiety in the Medically Ill. Psychiatric Times. 2017;32.
9 Cosci F, Fava GA, Sonino N. Mood and Anxiety Disorders as Early Manifestations of Medical Illness: A Systematic Review. Psychother Psychosom. 2015;84:22–9.
10 Leucht S, Hierl S, Kissling W, Dold M, Davis JM. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry. 2012;200:97–106.
11 Huhn M, Tardy M, Spineli LM, Kissling W, Förstl H, Pitschel-Walz G, et al. Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric Disorders. A Systematic Overview of Metaanalyses. JAMA Psychiatry. 2014;71:706–15.
12 Cuijpers P, van Straten A, Warmerdam L, et al. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26:279–88.
13 Simons AD, Murphy GE, Levine JL, Wetzel RD. Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry. 1986;43:43–8.
14 Sutej I. Pharmakotherapie und Psychotherapie bei unipolarer Depression. Ist die kombinierte Behandlung einer Monotherapie überlegen? Zeitschrift für Psychiatrie, Psychologie und Psychotherapie. 2006;54:163–72.
15 Spatola CA, Manzoni GM, Castelnuovo G, Malfatto G, Facchini M, Goodwin CL, et al. The ACTonHEART study: rationale and design of a randomized controlled clinical trial comparing a brief intervention based on Acceptance and Commitment Therapy to usual secondary prevention care of coronary heart disease. Health Qual Life Outcomes. 2014;12:22.
16 Jacka FN, O’Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017;15:23.
17 National Institute for Clinical Excellence (NICE). Depression: the treatment and management of depression in adults (update). Draft for consultation Feb 2009.
18 Lam RW, Gorman CP, Michalon M, et al. Multicenter, placebo-
controlled study of fluoxetine in seasonal affective disorder.
Am J Psychiatry. 1995;152:1765–70.
19 Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2001;21:718–79.
20 Tomonaga Y, Haettenschwiler J, Hatzinger M, Holsboer-Trachsler E, Rufer M, Hepp U, et al. The economic burden of depression in Switzerland. Pharmacoeconomics. 2013;31:237–50.